| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 3 147-157, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
T Uchiumi, K Kohno, H Tanimura, K Matsuo, S Sato, Y Uchida and M Kuwano
Department of Biochemistry, Oita Medical University, Japan.
The multidrug resistance 1 (MDR1) gene encodes a M(r) 170,000 membrane glycoprotein termed P-glycoprotein, which catalyzes the energy-dependent efflux of multiple anticancer agents. We investigated the activation of the MDR1 gene promoter by UV light irradiation in human cancer KB cells after both transient and stable transfection assays of the MDR1 promoter fused to the chloramphenicol acetyltransferase (CAT) gene. Following exposure to UV irradiation, CAT gene expression was about 20-fold increased. A series of promoter dissection analyses showed that two elements extending from -136 to -76 of the 5' flanking sequence and from +1 to +121 of the sequence downstream from the initiation site were required for the stress induction of MDR1 promoter activity. Gel shift assays showed that the specific DNA binding activities of the transacting protein to the MDR1 promoter were augmented in nuclear extracts from the cells treated with UV irradiation. A DNA sequence, an inverted CCAAT box, was identified that specifically bound to this protein, and mutation of this sequence abolished the binding of this protein. Two guanines in the inverted CCAAT box were found to be critical, as methylation of these guanines abrogated the binding. Nuclear run-on assay demonstrated that the transcription level was increased about 5-fold. These results suggest that the activation of the MDR1 promoter may result from transcriptional rather than posttranscriptional events. These studies will provide the basis for understanding the regulatory mechanism for appearance of the drug-resistant phenotype during cancer chemotherapy.
This article has been cited by other articles:
![]() |
R. Chattopadhyay, S. Das, A. K. Maiti, I. Boldogh, J. Xie, T. K. Hazra, K. Kohno, S. Mitra, and K. K. Bhakat Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1 Mol. Cell. Biol., December 1, 2008; 28(23): 7066 - 7080. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mantwill, N. Kohler-Vargas, A. Bernshausen, A. Bieler, H. Lage, A. Kaszubiak, P. Surowiak, T. Dravits, U. Treiber, R. Hartung, et al. Inhibition of the Multidrug-Resistant Phenotype by Targeting YB-1 with a Conditionally Oncolytic Adenovirus: Implications for Combinatorial Treatment Regimen with Chemotherapeutic Agents. Cancer Res., July 15, 2006; 66(14): 7195 - 7202. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wang, S. Ngoi, J. Wang, S. S. Chong, and C. G. L. Lee The Promoter Region of the MDR1 Gene Is Largely Invariant, but Different Single Nucleotide Polymorphism Haplotypes Affect MDR1 Promoter Activity Differently in Different Cell Lines Mol. Pharmacol., July 1, 2006; 70(1): 267 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Law, K. L. Cann, and G. G. Hicks TLS, EWS and TAF15: a model for transcriptional integration of gene expression Brief Funct Genomic Proteomic, March 1, 2006; 5(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yasen, K. Kajino, S. Kano, H. Tobita, J. Yamamoto, T. Uchiumi, S. Kon, M. Maeda, G. Obulhasim, S. Arii, et al. The Up-Regulation of Y-Box Binding Proteins (DNA Binding Protein A and Y-Box Binding Protein-1) as Prognostic Markers of Hepatocellular Carcinoma Clin. Cancer Res., October 15, 2005; 11(20): 7354 - 7361. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsujimura, K. Saito, S. Nakayamada, K. Nakano, J. Tsukada, K. Kohno, and Y. Tanaka Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes Genes Cells, December 1, 2004; 9(12): 1265 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuwano, Y. Oda, H. Izumi, S.-J. Yang, T. Uchiumi, Y. Iwamoto, M. Toi, T. Fujii, H. Yamana, H. Kinoshita, et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance Mol. Cancer Ther., November 1, 2004; 3(11): 1485 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Stein, K. Jurchott, M. Schlafke, and P. Hohenberger Expression of Multidrug Resistance Genes MVP, MDR1, and MRP1 Determined Sequentially Before, During, and After Hyperthermic Isolated Limb Perfusion of Soft Tissue Sarcoma and Melanoma Patients J. Clin. Oncol., August 1, 2002; 20(15): 3282 - 3292. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shibahara, K. Sugio, T. Osaki, T. Uchiumi, Y. Maehara, K. Kohno, K. Yasumoto, K. Sugimachi, and M. Kuwano Nuclear Expression of the Y-Box Binding Protein, YB-1, as a Novel Marker of Disease Progression in Non-Small Cell Lung Cancer Clin. Cancer Res., October 1, 2001; 7(10): 3151 - 3155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Albertus and R. Laine Enhanced xenobiotic transporter expression in normal teleost hepatocytes: response to environmental and chemotherapeutic toxins J. Exp. Biol., January 1, 2001; 204(2): 217 - 227. [Abstract] [PDF] |
||||
![]() |
Z. Hu, S. Jin, and K. W. Scotto Transcriptional Activation of the MDR1 Gene by UV Irradiation. ROLE OF NF-Y AND Sp1 J. Biol. Chem., January 28, 2000; 275(4): 2979 - 2985. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ziemann, A. Burkle, G. F. Kahl, and K. I. Hirsch-Ernst Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures Carcinogenesis, March 1, 1999; 20(3): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakayama, M. Wada, T. Harada, J. Nagayama, H. Kusaba, K. Ohshima, M. Kozuru, H. Komatsu, R. Ueda, and M. Kuwano Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias Blood, December 1, 1998; 92(11): 4296 - 4307. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhou and M. T. Kuo Wild-type p53-mediated Induction of Rat mdr1b Expression by the Anticancer Drug Daunorubicin J. Biol. Chem., June 19, 1998; 273(25): 15387 - 15394. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Toone, S. Kuge, M. Samuels, B. A. Morgan, T. Toda, and N. Jones Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1 Genes & Dev., May 15, 1998; 12(10): 1453 - 1463. [Abstract] [Full Text] |
||||
![]() |
M. Furukawa, T. Uchiumi, M. Nomoto, H. Takano, R. I. Morimoto, S. Naito, M. Kuwano, and K. Kohno The Role of an Inverted CCAAT Element in Transcriptional Activation of the Human DNA Topoisomerase IIalpha Gene by Heat Shock J. Biol. Chem., April 24, 1998; 273(17): 10550 - 10555. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohga, T. Uchiumi, Y. Makino, K. Koike, M. Wada, M. Kuwano, and K. Kohno Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene J. Biol. Chem., March 13, 1998; 273(11): 5997 - 6000. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhou and M. T. Kuo NF-kappa B-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells J. Biol. Chem., June 13, 1997; 272(24): 15174 - 15183. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sundseth, G. Macdonald, J. Ting, and A. C. King DNA Elements Recognizing NF-Y and Sp1 Regulate the Human Multidrug-Resistance Gene Promoter Mol. Pharmacol., June 1, 1997; 51(6): 963 - 971. [Abstract] [Full Text] |
||||
![]() |
K Torigoe, S Sato, H Kusaba, K Kohno, M Kuwano, K Okumura, E D Green, L C Tsui, S W Scherer, and D Schlessinger A YAC-based contig of 1.5 Mb spanning the human multidrug resistance gene region and delineating the amplification unit in three human multidrug-resistant cell lines. Genome Res., October 1, 1995; 5(3): 233 - 244. [Abstract] [PDF] |
||||
![]() |
H Kusaba, K Kohno, K Asakuno, M Kuwano, K Okumura, E D Green, D Schlessinger, and M Wada Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells. Genome Res., October 1, 1995; 5(3): 245 - 258. [Abstract] [PDF] |
||||
![]() |
L. Deng, Y.-C. Lin-Lee, F.-X. Claret, and M. T. Kuo 2-Acetylaminofluorene Up-regulates Rat mdr1b Expression through Generating Reactive Oxygen Species That Activate NF-kappa B Pathway J. Biol. Chem., January 5, 2001; 276(1): 413 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wartenberg, F. C. Ling, M. Schallenberg, A. T. Baumer, K. Petrat, J. Hescheler, and H. Sauer Down-regulation of Intrinsic P-glycoprotein Expression in Multicellular Prostate Tumor Spheroids by Reactive Oxygen Species J. Biol. Chem., May 11, 2001; 276(20): 17420 - 17428. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Stein, K. Jurchott, W. Walther, S. Bergmann, P. M. Schlag, and H.-D. Royer Hyperthermia-induced Nuclear Translocation of Transcription Factor YB-1 Leads to Enhanced Expression of Multidrug Resistance-related ABC Transporters J. Biol. Chem., July 20, 2001; 276(30): 28562 - 28569. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Vilaboa, A. Galan, A. Troyano, E. de Blas, and P. Aller Regulation of Multidrug Resistance 1 (MDR1)/P-glycoprotein Gene Expression and Activity by Heat-Shock Transcription Factor 1 (HSF1) J. Biol. Chem., August 4, 2000; 275(32): 24970 - 24976. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |